|
|
|
|
|
| Australia |
| World-first cream to treat skin cancer moves closer to reality |
A topical cream to help prevent and treat skin cancers in organ transplant patients is a step closer to development. The...Read more
- 30 November 2024 News
|
|
| China |
| Hong Kong lays focus on peptide drug innovation and discovery to pioneer collaboration in biopharma research |
The University of Hong Kong (HKU), represented by Versitech Limited, has signed an agreement with China Merchants Group ...Read more
- 30 November 2024 News
|
|
|
|
|
| Singapore |
| Singapore launches world’s first advanced degrees in sustainable healthcare for low-carbon future |
|
Climate change poses a direct and urgent threat to the health of patients and the viability of health systems in Asia, a...Read more
- 30 November 2024 News
|
|
| Korea |
| Newbase introduces VR medical training platform 'Medicrew', to accelerate global market expansion |
|
Newbase, a leader in metaverse-based medical education platforms, has announced the launch of its new product, 'Medicrew...Read more
- 30 November 2024 News
|
|
|
|
|
| World |
| Qiagen unveils novel tools for customising digital PCR assays and NGS panels for microbial analysis |
|
Qiagen has announced the launch of two new tools for designing and ordering custom solutions that can be used to support...Read more
- 30 November 2024 News
|
|
|
|
|
All you want to read on
|
|
|
This email has been sent to you in association with
www.biospectrumasia.com
Tell Us What You Think! Help us improve our newsletters.
Send us your feedback!
© Copyright 2020 MM ACTIV. All rights reserved.
To Unsubscribe click here.
Disclaimer : Please remember – by opting-in you are still able to opt-out at any time, by simply replying to this email at digital@mmactiv.com and typing 'unsubscribe' in the 'subject' field of any future emails. We promise only to send emails that we believe you will find interesting, relevant and current.
Your data will never be sold or shared with any third party, although we may communicate a message to you from a partner that we are in collaboration with.
|
|
|
